• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内镜下可切除的结直肠黏膜下癌淋巴结转移的预测性微小RNA

Predictive microRNAs for lymph node metastasis in endoscopically resectable submucosal colorectal cancer.

作者信息

Jung Chan Kwon, Jung Seung-Hyun, Yim Seon-Hee, Jung Ji-Han, Choi Hyun Joo, Kang Won-Kyung, Park Sung-Won, Oh Seong-Taek, Kim Jun-Gi, Lee Sug Hyung, Chung Yeun-Jun

机构信息

Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

Department of Microbiology, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

出版信息

Oncotarget. 2016 May 31;7(22):32902-15. doi: 10.18632/oncotarget.8766.

DOI:10.18632/oncotarget.8766
PMID:27096956
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5078061/
Abstract

Accurate prediction of regional lymph node metastasis (LNM) in endoscopically resected T1-stage colorectal cancers (CRCs) can reduce unnecessary surgeries. To identify miRNA markers that can predict LNM in T1-stage CRCs, the study was conducted in two phases; (I) miRNA classifier construction by miRNA-array and quantitative reverse transcription PCR (qRT-PCR) using 36 T1-stage CRC samples; (II) miRNA classifier validation in an independent set of 20 T1-stage CRC samples. The expression of potential downstream target genes of miRNAs was assessed by immunohistochemistry. In the discovery analysis by miRNA microarray, expression of 66 miRNAs were significantly different between LNM-positive and negative CRCs. After qRT-PCR validation, 11 miRNAs were consistently significant in the combined classifier construction set. Among them, miR-342-3p was the most significant one (P=4.3×10-4). Through logistic regression analysis, we developed a three-miRNA classifier (miR-342-3p, miR-361-3p, and miR-3621) for predicting LNM in T1-stage CRCs, yielding the area under the curve of 0.947 (94% sensitivity, 85% specificity and 89% accuracy). The discriminative ability of this system was consistently reliable in the independent validation set (83% sensitivity, 64% specificity and 70% of accuracy). Of the potential downstream targets of the three-miRNAs, expressions of E2F1, RAP2B, and AKT1 were significantly associated with LNM. In conclusion, this classifier can predict LNM more accurately than conventional pathologic criteria and our study results may be helpful to avoid unnecessary bowel surgery after endoscopic resection in early CRC.

摘要

准确预测经内镜切除的T1期结直肠癌(CRC)区域淋巴结转移(LNM)可减少不必要的手术。为了识别可预测T1期CRC中LNM的miRNA标志物,本研究分两个阶段进行:(I)使用36个T1期CRC样本,通过miRNA阵列和定量逆转录PCR(qRT-PCR)构建miRNA分类器;(II)在一组独立的20个T1期CRC样本中验证miRNA分类器。通过免疫组织化学评估miRNA潜在下游靶基因的表达。在miRNA微阵列的发现分析中,LNM阳性和阴性CRC之间66种miRNA的表达存在显著差异。经过qRT-PCR验证,11种miRNA在组合分类器构建集中始终具有显著性。其中,miR-342-3p最为显著(P=4.3×10-4)。通过逻辑回归分析,我们开发了一种用于预测T1期CRC中LNM的三miRNA分类器(miR-342-3p、miR-361-3p和miR-3621),曲线下面积为0.947(敏感性94%,特异性85%,准确性89%)。该系统的判别能力在独立验证集中始终可靠(敏感性83%,特异性64%,准确性70%)。在这三种miRNA的潜在下游靶标中,E2F1、RAP2B和AKT1的表达与LNM显著相关。总之,该分类器比传统病理标准能更准确地预测LNM,我们的研究结果可能有助于避免早期CRC内镜切除术后不必要的肠道手术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef4/5078061/8ff604f12c71/oncotarget-07-32902-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef4/5078061/9bd471505ca2/oncotarget-07-32902-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef4/5078061/7b4efe621ee2/oncotarget-07-32902-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef4/5078061/ab1e92c2431c/oncotarget-07-32902-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef4/5078061/211aa8071e43/oncotarget-07-32902-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef4/5078061/ec40a4841b4c/oncotarget-07-32902-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef4/5078061/8ff604f12c71/oncotarget-07-32902-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef4/5078061/9bd471505ca2/oncotarget-07-32902-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef4/5078061/7b4efe621ee2/oncotarget-07-32902-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef4/5078061/ab1e92c2431c/oncotarget-07-32902-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef4/5078061/211aa8071e43/oncotarget-07-32902-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef4/5078061/ec40a4841b4c/oncotarget-07-32902-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef4/5078061/8ff604f12c71/oncotarget-07-32902-g006.jpg

相似文献

1
Predictive microRNAs for lymph node metastasis in endoscopically resectable submucosal colorectal cancer.内镜下可切除的结直肠黏膜下癌淋巴结转移的预测性微小RNA
Oncotarget. 2016 May 31;7(22):32902-15. doi: 10.18632/oncotarget.8766.
2
A Liquid Biopsy Assay for Noninvasive Identification of Lymph Node Metastases in T1 Colorectal Cancer.液体活检在 T1 结直肠癌中用于非侵入性识别淋巴结转移的检测。
Gastroenterology. 2021 Jul;161(1):151-162.e1. doi: 10.1053/j.gastro.2021.03.062. Epub 2021 Apr 2.
3
A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.一个包含 4 个 miRNA 的标志物可预测乳腺癌的淋巴结转移和预后。
Hum Pathol. 2018 Jun;76:122-132. doi: 10.1016/j.humpath.2018.03.010. Epub 2018 Mar 17.
4
The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.miR-1和miR-374b作为结直肠癌生物标志物的潜在价值。
Int J Clin Exp Pathol. 2015 Mar 1;8(3):2840-51. eCollection 2015.
5
Early metastatic colorectal cancers show increased tissue expression of miR-17/92 cluster members in the invasive tumor front.早期转移性结直肠癌在侵袭性肿瘤前缘表现出 miR-17/92 簇成员的组织表达增加。
Hum Pathol. 2018 Oct;80:231-238. doi: 10.1016/j.humpath.2018.05.027. Epub 2018 Jun 11.
6
MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.miRNA-362-3p 通过靶向 E2F1、USF2 和 PTPN1 诱导细胞周期停滞,与结直肠癌的复发相关。
Int J Cancer. 2013 Jul;133(1):67-78. doi: 10.1002/ijc.28010. Epub 2013 Feb 12.
7
A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph Nodes.与T1期结直肠癌淋巴结转移相关的微小RNA特征
Gastroenterology. 2018 Mar;154(4):844-848.e7. doi: 10.1053/j.gastro.2017.11.275. Epub 2017 Dec 2.
8
Predictors for lymph node metastasis in T1 colorectal cancer.T1 结直肠癌淋巴结转移的预测因素。
Endoscopy. 2012 Jun;44(6):590-5. doi: 10.1055/s-0031-1291665. Epub 2012 May 25.
9
Identification and external validation of a novel miRNA signature for lymph node metastasis prediction in submucosal-invasive gastric cancer patients.鉴定和外部验证用于预测黏膜下浸润性胃癌患者淋巴结转移的新型 miRNA 标志物。
Cancer Med. 2019 Oct;8(14):6315-6325. doi: 10.1002/cam4.2530. Epub 2019 Sep 4.
10
Diagnostic Value Investigation and Bioinformatics Analysis of miR-31 in Patients with Lymph Node Metastasis of Colorectal Cancer.miR-31 在结直肠癌淋巴结转移患者中的诊断价值研究及生物信息学分析。
Anal Cell Pathol (Amst). 2019 Dec 16;2019:9740475. doi: 10.1155/2019/9740475. eCollection 2019.

引用本文的文献

1
Comparative microRNA signatures based on liquid biopsy to identify lymph node metastasis in T1 colorectal cancer patients undergoing upfront surgery or endoscopic resection.基于液体活检的比较性微小RNA特征,用于识别接受初次手术或内镜切除的T1期结直肠癌患者的淋巴结转移情况。
Cell Death Discov. 2025 Feb 20;11(1):67. doi: 10.1038/s41420-025-02348-5.
2
Inhibiting S-palmitoylation arrests metastasis by relocating Rap2b from plasma membrane in colorectal cancer.抑制 S-棕榈酰化作用通过将 Rap2b 从结直肠癌细胞的质膜重新定位来阻止转移。
Cell Death Dis. 2024 Sep 14;15(9):675. doi: 10.1038/s41419-024-07061-2.
3
Screening microRNAs as potential prognostic biomarkers for lung adenocarcinoma.

本文引用的文献

1
miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer.miR-342-3p通过直接抑制E2F1来调节人肺癌中的MYC转录活性。
Carcinogenesis. 2015 Dec;36(12):1464-73. doi: 10.1093/carcin/bgv152. Epub 2015 Oct 18.
2
E2F1 promote the aggressiveness of human colorectal cancer by activating the ribonucleotide reductase small subunit M2.E2F1通过激活核糖核苷酸还原酶小亚基M2促进人类结直肠癌的侵袭性。
Biochem Biophys Res Commun. 2015 Aug 21;464(2):407-15. doi: 10.1016/j.bbrc.2015.06.103. Epub 2015 Jun 18.
3
MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1.
筛选 microRNAs 作为肺腺癌潜在的预后生物标志物。
Ann Med. 2023;55(2):2241013. doi: 10.1080/07853890.2023.2241013. Epub 2023 Nov 6.
4
Tumor-infiltrating T cells as a risk factor for lymph node metastasis in patients with submucosal colorectal cancer.肿瘤浸润 T 细胞是黏膜下结直肠癌患者淋巴结转移的危险因素。
Sci Rep. 2023 Feb 6;13(1):2077. doi: 10.1038/s41598-023-29260-1.
5
Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy.促进或缓解:非编码 RNA 在结直肠癌抗 EGFR 治疗中的作用。
Cell Commun Signal. 2022 Sep 21;20(1):150. doi: 10.1186/s12964-022-00960-x.
6
LASSO-Based Machine Learning Algorithm for Prediction of Lymph Node Metastasis in T1 Colorectal Cancer.基于 LASSO 的机器学习算法在 T1 结直肠癌淋巴结转移预测中的应用。
Cancer Res Treat. 2021 Jul;53(3):773-783. doi: 10.4143/crt.2020.974. Epub 2020 Dec 29.
7
Exosomal LncRNA LINC00659 transferred from cancer-associated fibroblasts promotes colorectal cancer cell progression via miR-342-3p/ANXA2 axis.外泌体 LncRNA LINC00659 来源于肿瘤相关成纤维细胞,通过 miR-342-3p/ANXA2 轴促进结直肠癌细胞的进展。
J Transl Med. 2021 Jan 6;19(1):8. doi: 10.1186/s12967-020-02648-7.
8
Identification and external validation of a novel miRNA signature for lymph node metastasis prediction in submucosal-invasive gastric cancer patients.鉴定和外部验证用于预测黏膜下浸润性胃癌患者淋巴结转移的新型 miRNA 标志物。
Cancer Med. 2019 Oct;8(14):6315-6325. doi: 10.1002/cam4.2530. Epub 2019 Sep 4.
9
Novel Molecular Characterization of Colorectal Primary Tumors Based on miRNAs.基于微小RNA的结直肠癌原发肿瘤的新型分子特征分析
Cancers (Basel). 2019 Mar 11;11(3):346. doi: 10.3390/cancers11030346.
10
Preserved miR-361-3p Expression Is an Independent Prognostic Indicator of Favorable Survival in Cervical Cancer.miR-361-3p 表达水平的保存是宫颈癌患者预后良好的独立预测指标。
Dis Markers. 2018 Sep 23;2018:8949606. doi: 10.1155/2018/8949606. eCollection 2018.
微小RNA-361-5p通过靶向含葡萄球菌核酸酶结构域-1抑制结直肠癌和胃癌的生长与转移。
Oncotarget. 2015 Jul 10;6(19):17404-16. doi: 10.18632/oncotarget.3744.
4
Novel molecular insights from routine genotyping of colorectal carcinomas.来自结直肠癌常规基因分型的新分子见解。
Hum Pathol. 2015 Apr;46(4):507-13. doi: 10.1016/j.humpath.2015.01.005. Epub 2015 Jan 14.
5
miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells.微小RNA-342-3p靶向RAP2B以抑制非小细胞肺癌细胞的增殖和侵袭。
Tumour Biol. 2015 Jul;36(7):5031-8. doi: 10.1007/s13277-015-3154-3. Epub 2015 Feb 9.
6
microRNA-548l is involved in the migration and invasion of non-small cell lung cancer by targeting the AKT1 signaling pathway.微小RNA-548l通过靶向AKT1信号通路参与非小细胞肺癌的迁移和侵袭。
J Cancer Res Clin Oncol. 2015 Mar;141(3):431-41. doi: 10.1007/s00432-014-1836-7. Epub 2014 Sep 23.
7
Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma.血清微小RNA检测 panel作为结直肠癌早期诊断的生物标志物
Br J Cancer. 2014 Nov 11;111(10):1985-92. doi: 10.1038/bjc.2014.489. Epub 2014 Sep 18.
8
miR-150 functions as a tumour suppressor in human colorectal cancer by targeting c-Myb.微小RNA-150通过靶向c-Myb在人类结直肠癌中发挥肿瘤抑制作用。
J Cell Mol Med. 2014 Oct;18(10):2125-34. doi: 10.1111/jcmm.12398. Epub 2014 Sep 18.
9
miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.微小RNA-99a通过靶向AKT1信号通路抑制人非小细胞肺癌细胞的转移。
J Cell Biochem. 2015 Feb;116(2):268-76. doi: 10.1002/jcb.24965.
10
miR-342-3p suppresses proliferation, migration and invasion by targeting FOXM1 in human cervical cancer.miR-342-3p通过靶向FOXM1抑制人宫颈癌的增殖、迁移和侵袭。
FEBS Lett. 2014 Aug 25;588(17):3298-307. doi: 10.1016/j.febslet.2014.07.020. Epub 2014 Jul 24.